Acute Myeloid Leukemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
Researchers show how DPF2 protein controls blood cell production in leukemia

Researchers show how DPF2 protein controls blood cell production in leukemia

Researchers identify new drug target for two common types of myeloid leukemia

Researchers identify new drug target for two common types of myeloid leukemia

UT Health scientists discover epigenetic changes that contribute to AML

UT Health scientists discover epigenetic changes that contribute to AML

FDA approves new AML drug after clinical testing at Dana-Farber

FDA approves new AML drug after clinical testing at Dana-Farber

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Formaldehyde exposure not linked to leukemia, research shows

Formaldehyde exposure not linked to leukemia, research shows

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

Second cancers are far deadlier in younger people than older adults

Second cancers are far deadlier in younger people than older adults

Scientists discover potential trigger for MDS in children with rare genetic disorder

Scientists discover potential trigger for MDS in children with rare genetic disorder

Scientists show p300 protein may stop MDS from developing into leukemia

Scientists show p300 protein may stop MDS from developing into leukemia

FDA approves new maintenance therapy for recurrent cancers

FDA approves new maintenance therapy for recurrent cancers

New study correlates 80 cancer-related gene mutations with 34 AML subgroups

New study correlates 80 cancer-related gene mutations with 34 AML subgroups

Early death from pediatric cancer subtypes more likely to happen than previously reported

Early death from pediatric cancer subtypes more likely to happen than previously reported

Research findings could guide development of potent combination therapies for leukemia

Research findings could guide development of potent combination therapies for leukemia

Clinical study seeks to examine new combination therapy for treating AML patients

Clinical study seeks to examine new combination therapy for treating AML patients

Study establishes ENL protein as potential drug target for acute myeloid leukemia

Study establishes ENL protein as potential drug target for acute myeloid leukemia

Researchers looking at ways to target lingering cancer stem cells that cause disease relapse

Researchers looking at ways to target lingering cancer stem cells that cause disease relapse

Fred Hutch scientists make important step in identifying specific T cells to fight against cancer

Fred Hutch scientists make important step in identifying specific T cells to fight against cancer

Targeting tumor suppressor protein could be effective treatment for some AML patients, study suggests

Targeting tumor suppressor protein could be effective treatment for some AML patients, study suggests

Young adults, adolescents with acute leukemia treated at specialized cancer centers have higher survival rates

Young adults, adolescents with acute leukemia treated at specialized cancer centers have higher survival rates